Safinamide in Clinical Practice: A Spanish Multicenter Cohort Study

Background: Safinamide is an approved drug for the treatment of motor fluctuations of Parkinson’s Disease (PD) patients with a potential benefit on non-motor symptoms (NMS). Methods: A retrospective multicenter cohort study was conducted, in which the clinical effect of safinamide on both motor and...

Descripción completa

Detalles Bibliográficos
Autores principales: Martí-Andrés, Gloria, Jiménez-Bolaños, Rayco, Arbelo-González, José Matias, Pagonabarraga, Javier, Duran-Herrera, Carmen, Valenti-Azcarate, Rafael, Luquin, Mª Rosario
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6826846/
https://www.ncbi.nlm.nih.gov/pubmed/31614574
http://dx.doi.org/10.3390/brainsci9100272

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6826846/
https://www.ncbi.nlm.nih.gov/pubmed/31614574
http://dx.doi.org/10.3390/brainsci9100272

Ejemplares similares